IQVIA Holdings Inc.
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: BBG00333FYS2
IQV
IQVIA Holdings Inc.
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Diagnostics & Research
NAME
IQVIA Holdings Inc.
ISIN
US46266C1053
TICKER
IQV
MIC
XNYS
REUTERS
IQV.N
BLOOMBERG
IQV US
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Thu, 06.02.2025
IQVIA
US46266C1053
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended December 31, 2024.
"IQVIA delivered excellent fourth quarter performance, closing out a strong 20...
Tue, 04.02.2025
IQVIA
US46266C1053
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, was named No. 1 in its category on the 2025 Fortune® World’s Most Admired Companies™ list. This is the fourth year in a row IQVIA has earned first place in the Health Care: Pharmacy and Other Services category, and the eighth...
Tue, 21.01.2025
IQVIA
US46266C1053
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 6, 2025. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be ...
Mon, 13.01.2025
IQVIA
US46266C1053
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights, and healthcare intelligence, today announced a strategic collaboration with NVIDIA to help realize the potential of AI in healthcare and life sciences.
The healthcare and life sciences industries generate vast amounts of data, representing significant...
Mon, 23.12.2024
IQVIA
US46266C1053
Despite a drop in venture funding for digital health companies over the last two-and-a-half years, digital health products and solutions are expanding in scope and function to aid patient diagnosis, treatment, and monitoring. More solutions are now focused on specific diseases, and their commercial appeal has grown as developers build solutions th...
Wed, 06.11.2024
IQVIA
US46266C1053
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the UBS Healthcare Conference in Rancho Palos Verdes, California on Wednesday, November 13, 2024 at 1:15 p.m. ET.
A live audio webcast of the presentation will be available on the IQVIA Investor Relation...
Thu, 31.10.2024
IQVIA
US46266C1053
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2024.
Third-Quarter 2024 Operating Results
Revenue for the third quarter of $3,896 m...
Tue, 15.10.2024
IQVIA
US46266C1053
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the I...
Wed, 02.10.2024
IQVIA
US46266C1053
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today introduces IQVIA AI Assistant, a generative AI technology that enables a step-change enhancement in how life science customers receive timely and powerful insights.
IQVIA ...
Wed, 21.08.2024
IQVIA
US46266C1053
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Morgan Stanley Annual Healthcare Conference in New York on Wednesday, September 4, 2024 at 10:00 a.m. ET.
A live audio webcast of the presentation will be available on the IQVIA Investor Relations w...
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
